FDA Approved: ETODOLAC — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

The FDA has approved a supplemental application for etodolac submitted by Chartwell RX, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• Etodolac (Etodolac)

Snippet

SUPPL AP for ETODOLAC (ETODOLAC)